GENE ONLINE|News &
Opinion
Blog

Phase 3 Trial
COVID-19 Stem Cell Therapy
Novartis Secures Exclusive Rights of Mesoblast’s Cell Therapy for COVID-19 Related ARDS
2020-11-21
Trials & Approvals Amyotrophic Lateral Sclerosis
Brainstorm’s Stem Cell Therapy Flunks Phase 3 ALS Trial
2020-11-20
COVID-19 Vaccine
How Does Moderna’s mRNA Vaccine Measure Up to Pfizer’s?
2020-11-16
COVID-19 Vaccine
Moderna’s Shares Surge Following Claims of 94.5% Efficacy for its COVID-19 Vaccine
2020-11-16
Trials & Approvals Atopic Dermatitis
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
Trials & Approvals Asthma
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
COVID-19 Vaccine
Interim Analysis Shows Pfizer & BioNTech’s COVID-19 Vaccine is 90% Effective
2020-11-09
Trials & Approvals
Bristol Myers Squibb’s Deucravacitinib Impresses in Phase 3 Psoriasis Trial
2020-11-04
R&D PD-L1
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
COVID-19 Inactivated Vaccine
Philippines Says Phase 3 Trial of Sinovac’s CoronaVac May Start in November
2020-10-19
Trials & Approvals
FDA Approves Venetoclax Combination for New Acute Myeloid Leukemia Cases
2020-10-19
COVID-19 Vaccine
After AZ, Another Big Pharma Halts COVID-19 Vaccine Trial Due to Patient Illness
2020-10-13
Trials & Approvals Gene Therapy
Pfizer, Sangamo Dose First Hemophilia A Patient in Phase 3 with Gene Therapy Candidate
2020-10-08
COVID-19 Vaccine
COVID-19: J&J’s Vaccine Candidate Registers Strong Immune Response in Early Trials
2020-09-29
Trials & Approvals
Novartis’ Asciminib Shines in Chronic Myeloid Leukemia Trial
2020-08-28
1 2 3 4 5 6
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top